|
|
|
| Clinical Efficacy and Safety Observation of Goserelin Combined with Laparoscopic Surgery in the Treatment of Endometriosis Complicated with Infertility Patients |
| LIU Li, SHI Guanghui, ZHENG Zhenli |
| Department of Obstetrics and Gynecology, Zhoukou Central Hospital,Zhoukou Henan 466000 |
|
|
|
Abstract 【Objective】 To explore the clinical efficacy and safety of goserelin combined with laparoscopic surgery in the treatment of endometriosis complicated with infertility patients.【Methods】A total of 88 patients with endometriosis complicated with infertility admitted to our hospital from July 2019 to July 2020 were randomly divided into the observation group (treated with goserelin combined with laparoscopic surgery) and the control group (treated with laparoscopic surgery) according to a random number table method, with 44 cases in each group. Two groups were compared in terms of treatment efficacy, overall incidence of adverse reactions during treatment, recurrence rate and pregnancy rate of endometriosis 2 years after surgery, as well as serum follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), glutathione peroxidase (GSH-PX), and reactive oxygen species (ROS) levels before and 6 months after treatment.【Result】The total effective rate of the observation group was significantly higher than that of the control group (P<0.05). After treatment, the levels of FSH, LH, E2, and ROS in both groups were significantly lower than before treatment, and the levels of FSH, LH, E2, and ROS in the observation group were lower than those in the control group (P<0.05); After treatment, the levels of GSH-PX in both groups were significantly higher than before treatment, and the observation group had higher levels of GSH-PX than the control group. There was no statistically significant difference in the total incidence of adverse reactions between the two groups (P>0.05). The recurrence rate of the observation group was significantly lower than that of the control group (P<0.05), and the pregnancy rate was significantly higher than that of the control group (P<0.05). 【Conclusion】 The combination of goserelin and laparoscopic surgery is effective in the treatment of endometriosis complicated with infertility. It can regulate the patient's sex hormone levels, improve oxidative stress response, reduce recurrence rate, increase pregnancy rate, and has good safety.
|
|
Received: 06 September 2022
|
|
|
|
|
|
[1] SAAVALAINEN L, LASSUS H, BUT A, et al. Incidence of extraovarian clear cell cancers in women with surgically diagnosed endometriosis: A cohort study[J].PLoS One,2021, 16(6):e0253270.
[2] HODGSON R M, LEE H L, WANG R, et al. Interventions for endometriosis-related infertility:a systematic review and network meta-analysis[J].Fertil Steril,2020, 113(2):374-382.
[3] 王飞. 米非司酮联合腹腔镜手术治疗卵巢子宫内膜异位症不孕的临床疗效分析[J].中国医疗器械信息, 2019, 25(4):67-68.
[4] 闫喜秋. 腹腔镜手术联合戈舍瑞林对子宫内膜异位症合并不孕症患者血清MMP-9、TIMP-1表达的影响[J].中国医学创新, 2020,17(1):165-168.
[5] 中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症的诊治指南[J].中华妇产科杂志, 2015, 29(3):161-169.
[6] 陈建明. 实用不孕不育诊断与治疗[M]. 广东:广东科技出版社, 2013:87-89.
[7] 罗健. 八珍汤联合醋酸戈舍瑞林缓释植入剂治疗子宫内膜异位症的疗效及安全性分析[J].辽宁中医杂志, 2019, 46(8):1676-1679.
[8] 伍秋红, 蒋庆源, 孙丽,等. 戈舍瑞林联合腹腔镜手术治疗子宫内膜异位症合并不孕症疗效[J].中国计划生育学杂志, 2021, 29(4):694-697.
[9] 赵向阳,魏亚楠.孕酮、子宫内膜异位症生育指数与子宫内膜异位症伴不孕患者术后妊娠结局的相关性分析[J].医学临床研究,2024,41(1):150-152.
[10] TANBO T, FEDORCSAK P. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options[J].Acta Obstet Gynecol Scand,2017, 96(6):659-667.
[11] 严维娜, 曲红卫, 董利平. 消痞止痛破瘀汤联合醋酸戈舍瑞林缓释植入剂对子宫内膜异位症腹腔镜术后激素水平及其标志物含量的影响[J].国际中医中药杂志, 2019, 41(9):921-925.
[12] 侯丽娟, 翟建军, 曹京红,等. 腹腔镜手术联合GnRH-a治疗子宫内膜异位症临床效果及对患者卵巢功能的影响[J].山东医药, 2019, 59(14):81-83.
[13] 张小莎, 张伟. 活血化瘀中药联合腹腔镜手术对子宫内膜异位症不孕患者MCP-1、RANTES、氧化应激及性激素水平的影响[J].海南医学院学报, 2017, 23(21):2956-2959.
[14] 陈爱平, 蔡长争, 陈丽花,等. 促性腺激素释放激素激动剂对子宫内膜异位症腹腔镜术后患者症状缓解率及复发率的影响[J].中国计划生育和妇产科, 2017, 9(12):53-56.
[15] 李晨洁. 腹腔镜手术联合戈舍瑞林治疗子宫内膜异位症患者效果观察[J].实用妇科内分泌杂志(电子版), 2017, 4(1):30-31. |
|
|
|
2024, Vol. 41 
